Breast cancer risk scores change over time, with those who go on to develop cancer showing unique patterns that could provide valuable guidance into their diagnostic needs.
The manufacturer issued an alert in January, indicating its Brevera Breast Biopsy System Disposable 9 Gauge Needles were being recalled amid risk they might leave metallic particles in tissue.
Plaintiff attorneys believe this is the largest non-death-related malpractice payout in the history of Maine, with Brewer-based Northern Light Health system on the hook for the damages.
The Nashville, Tennessee, company—which offers AI to monitor radiology reports for unexpected findings—has reached a deal to buy Thynk Health for an undisclosed sum.
Chicago imaging leaders have sought to address isolation and its ill effects through the implementation of daily “happy birthday” emails to department employees.
The Redwood City, California-based startup says it is seeking to hire multiple remote physicians, claiming it’s offering “not just another job” but a “better way to practice.”
The COlorectal Cancer detection with AI, or COCA, model is a cost-effective, scalable solution that turns routine CT scans into opportunistic exams that can be used to proactively identify CRC.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.
